These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10532305)

  • 1. Recombinant allergens for specific immunotherapy.
    Valenta R; Vrtala S
    Allergy; 1999; 54 Suppl 56():43-4. PubMed ID: 10532305
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-tailored recombinant allergen products--mission impossible?
    Cromwell O; Matricardi PM; Fiebig H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():210-7; discussion 217-8. PubMed ID: 20799463
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant allergens for specific immunotherapy.
    Cromwell O; Häfner D; Nandy A
    J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical testing of recombinant allergens of the mold Alternaria alternata.
    Unger A; Stöger P; Simon-Nobbe B; Susani M; Crameri R; Ebner C; Hintner H; Breitenbach M
    Int Arch Allergy Immunol; 1999; 118(2-4):220-1. PubMed ID: 10224387
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant allergens.
    Valenta R; Vrtala S; Laffer S; Spitzauer S; Kraft D
    Allergy; 1998 Jun; 53(6):552-61. PubMed ID: 9689336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

  • 10. [Natural allergens and recombinant allergens].
    Deviller P
    Allerg Immunol (Paris); 1995 Nov; 27(9):316-9. PubMed ID: 8590581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic engineering of allergens: future therapeutic products.
    Ferreira F; Wallner M; Breiteneder H; Hartl A; Thalhamer J; Ebner C
    Int Arch Allergy Immunol; 2002 Jul; 128(3):171-8. PubMed ID: 12119498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant allergens; basic and practical considerations.
    Breiteneder H; Hoffmann-Sommergruber K; Vanek-Krebitz M; Kraft D; Scheiner O
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):80-6. PubMed ID: 9383894
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives.
    Pauli G; Purohit A; Oster JP; de Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1999; 118(2-4):216-7. PubMed ID: 10224385
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspective of purified natural and recombinant allergens in diagnosis and treatment of inhalant allergies.
    van Ree R; van Leeuwen A; Bond J; Aalberse R
    Int Arch Allergy Immunol; 1999; 118(2-4):212-3. PubMed ID: 10224383
    [No Abstract]   [Full Text] [Related]  

  • 15. Dusting off recombinant allergens.
    Marshall GD; Davis F
    Nat Biotechnol; 1997 Aug; 15(8):718-9. PubMed ID: 9255778
    [No Abstract]   [Full Text] [Related]  

  • 16. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy coming of age: notable advances during the first hundred years.
    Nelson HS
    Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of molecular biology on allergen immunotherapy.
    Bush RK
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):557-8. PubMed ID: 21030836
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.